Evidence map›Paper›PMID 32660442›Full record

Trial reportBMC medical research methodology2020

Quality of evidence in a post-Soviet country: evaluation of methodological quality of controlled clinical trials published in national journals from Uzbekistan.

Timur Aripov, Dilfuza Aniyozova, Irina Gorbunova

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC medical research methodology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Timur AripovDepartment of Public Health and Healthcare Management, Tashkent Institute of Postgraduate Medical Education, Parkentskaya str. 51, Tashkent, Uzbekistan, 100007. timur_aripov@yahoo.com.ORCID 0000-0003-2548-9888
Dilfuza AniyozovaPrincipal investigator at Antimicrobial Resistance Research project, Tashkent Institute of Postgraduate Medical Education, Parkentskaya str. 51, Tashkent, Uzbekistan, 100007.
Irina GorbunovaDepartment of Public Health and Healthcare Management, Tashkent Institute of Postgraduate Medical Education, Parkentskaya str. 51, Tashkent, Uzbekistan, 100007.

Funding

International Bioethics Research Postdoctoral Training - C. Asia NetworkD43TW011237 · FIC · BOSTON CHILDREN'S HOSPITAL · PI MUNIR, KERIM M · 2019 to 2023
$1.2M
FIC NIH HHS D43 TW011237
6 · The paper itself

Abstract

backgroundMost researchers in Uzbekistan prefer to publish their reports in journals of their home country. Moreover, the proportion of healthcare practitioners who prefer to use these national sources of information also remains high. However, the quality of publications from national journals, in post-Soviet countries, has not been systematically evaluated until now. The primary objective of this study was to evaluate the quality of randomized controlled trials' (RCTs) reports published in medical journals from Uzbekistan. We supposed that reports had at least minimal quality to contribute to the higher quality of healthcare.

methodsTo evaluate the quality of RCTs, we selected two journals from the list of national medical journals for which background information was provided. We decided to select articles from journals that had the highest subscription rate and were likely to have the highest impact on clinical decisions. The journals were Medical Journal of Uzbekistan and Paediatrics. Only issues published in 2007-2017 were considered for evaluation. Two evaluators independently scored RCTs and controlled clinical trials (CCTs) reported in the journals. The 5-point scale developed by Jadad et al. was used to evaluate the quality of reports. Consensus-based decision was made about the final score of each report.

resultsWe reviewed 1311 studies in the two journals and found 380 clinical trials reports for the final evaluation. Our main finding was that none of the reports received a final score of more than 1, with an absolute agreement between evaluators. A median score of the studied reports was equal to 0, predicting a very low quality of controlled trials reported in the national journals (Wilcoxon signed-rank test p = 1.0; 95% CI = 0-0).

conclusionsWe believe that quality of reports about controlled trials, in Uzbekistan, can be considered insufficient to contribute to the higher quality of care and patients' safety. In the worst case, such condition can cause serious damage to the public health and lead to ineffective use of resources in the country. Therefore, the better reporting and organization of RCTs and CCTs should become a main goal of all stakeholders interested in the effective and safe healthcare in the country.

Indexed as

Periodicals as TopicChildHumansPublicationsUzbekistanEvidence-based medicineHealthcare qualityPublic healthRandomized controlled trialUzbekistan

Identifiers

PMID32660442
PMCPMC7359460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.